Concepedia
1
Publications
194
Citations
H-Index
2022
Active since
Affiliations
National Institutes of Health(Current)
Matthew T. Koster is an author at National Institutes of Health.
Publications per year
2022–2022
Ruxolitinib is more effective than other JAK inhibitors to treat VEXAS syndrome: a retrospective multicenter study
Maël Heiblig, Marcela A. Ferrada, Matthew T. Koster et al. · Blood · 2022 · 194 citations · Full text
Rows per page
1–1 of 1